S. Aronson

Cost-effectiveness and quality of life in psychosis: the pharmacoeconomics of risperidone.

S. Aronson, 1997, Clinical therapeutics.

A peptide enhancement strategy in Alzheimer's disease: Pilot study with TRH-physostigmine infusions

S. Berent, B. Giordani, A. Mellow, 1993, Biological Psychiatry.

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer’s Disease

S. Kavanagh, B. Baelen, S. Schwalen, 2009, Drugs & aging.

Treatment of Behaviorally Disturbed Elderly Patients: A Clinical Approach

S. Aronson, 1998 .

Retrospective Review of Selective Serotonin Reuptake Inhibitors and Falling in Older Nursing Home Residents

C. Arfken, Jacquelyn G. Wilson, S. Aronson, 2001, International Psychogeriatrics.